Page 442 - ILAE_Lectures_2015
P. 442

risk of bone demineralisation, especially if they are receiving a hepatic enzyme-inducing
AED (phenobarbitone, phenytoin, and carbamazepine), which can accelerate vitamin D
metabolism167,168. Both seizures and AEDs affect the hypothalamic-pituitary-adrenal axis,
which can have an adverse impact on bone health. No assessment has been made on the
optimal frequency with which women on long-term AEDs should have bone density
monitored. In the general population, hormone replacement therapy (combined oestrogen and
progesterone) appears to have beneficial effects in postmenopausal women and it should be
offered to postmenopausal women with epilepsy if it is clinically indicated169.

References

      1. LUEF G (2010) Hormonal alterations following seizures. Epilepsy Behav 19, 131-133.
      2. PACK AM, REDDY DS, DUNCAN S, HERZOG A (2011) Neuroendocrinological aspects of epilepsy:

            Important issues and trends for future research. Epilepsy Behav 94, 102-122.
      3. VEROTTI A, D’EGIDIO C, MOHN A, COPPOLA G, PARISI P, CHIARELLI F (2011) Antiepileptic

            drugs, sex hormones, and PCOS. Epilepsia 52(2), 199-211.
      4. PACK AM (2010) Implications of hormonal and neuro-endocrine changes associated with seizures and

            antiepilepsy drugs: a clinical perspective. Epilepsia 51(Suppl.3). 150-153.
      5. LOGOTHETIS J, HARNER R, MORRELL F, TORRES F (1958) The role of estrogens in catamenial

            exacerbation of epilepsy. Neurology 9, 353-360.
      6. BACKSTROM T, ZETTERLUND B, BLOM S, ROMANO M (1984) Effects of intravenous

            progesterone infusions on the epileptic discharge frequency in women with partial epilepsy. Acta Neurol
            Scand 69, 240-248.
      7. BETTS T and CRAWFORD PM (1999) Epilepsy in Women. Martin Dunitz, London.
      8. BACKSTROM T (1976) Epileptic seizures in women related to plasma estrogen and progesterone during the
            menstrual cycle. Acta Neurol Scand 54, 321-347.
      9. MATTSON RH, KRAMER JA, CALDWELL BVV et al (1981) Seizure frequency and the menstrual cycle:
            a clinical study. Epilepsia 22, 242.
      10. HERZOG AG, KLEIN P and RANSIL BJ (1997) Three patterns of catamenial epilepsy. Epilepsia 38, 1082-
            1088.
      11. DUNCAN S, READ CL, BRODIE MJ (1993) How common is catamenial epilepsy? Epilepsia 34, 827-831.
      12. REDDY DS, ROGAWSKI MA (2009) Neurosteroid replacement therapy for catamenial epilepsy.
            Neurotherapeutics 6, 392-401.
      13. ROSCISZEWSKA D, BUNTNER B, GUZ I et al (1986) Ovarian hormones, anticonvulsant drugs and seizures
            during the menstrual cycle in women with epilepsy. J Neurol Neurosurg Psychiatr 49, 47-51.
      14. CRAWFORD PM (1991) Catamenial epilepsy. In: Epilepsy and Women (Ed. MR Trimble), pp.159-165. J.
            Wiley & Sons, Chichester.
      15. LIM LL, FOLDVARY N, MASCHA E, LEE J (2001) Acetazolamide in women with catamenial epilepsy.
            Epilepsia 42, 746-749.
      16. DANA-HAERI J, RICHENS A (1983) Effects of norethisterone on seizures associated with menstruation.
            Epilepsia 24, 377-381.
      17. HERZOG AG (1999) Progesterone therapy in women with epilepsy: a 3-year follow-up. Neurology 52, 1917-
            1918.
      18. MATTSON RH, CRAMER JA, CALDWELL BV et al (1984) Treatment of seizures with
            medroxyprogesterone acetate: preliminary report. Neurology (Cleveland) 34, 1255-1258.
      19. HERZOG AG, FRYE CA (2003) Seizure exacerbation associated with inhibition of progesterone metabolism.
            Ann Neurol 53, 390-391.
      20. REDDY DS, CASTANEDA DC, O’MALLEY BW, ROGAWSKI MA (2004) Anticonvulsant activity of
            progesterone and neurosteroids in progesterone receptor knockout mice. J Pharmacol Exp Ther 310, 230-239.
      21. HERZOG AG, FRYE CA (2003) Seizure exacerbation associated with inhibition of progesterone metabolism.
            Ann Neurol 53, 390-391.
      22. FEELY M, GIBSON J (1984) Intermittent clobazam for catamenial epilepsy: tolerance avoided. J Neurol
            Neurosurg Psychiatry 47, 1279-1282.
      23. HERZOG AG (1988) Clomiphene therapy in epileptic women with menstrual disorders. Neurology 38, 432-
            434.
      24. HERZOG AG, SEIBEL MM, SCHOMER DL, VAITUKAITIS JL, GESCHWIND N (1986) Reproductive
            endocrine disorders in women with partial seizures of temporal lobe origin. Arch Neurol 43, 341-345.
      25. CUMMINGS LN, GIUDICE L, MORRELL MJ (1995) Ovulatory function in epilepsy. Epilepsia 36, 353-
            357.
      26. HERZOG AG (1986) Intermittent progesterone therapy and frequency of complex partial seizures in women
            with menstrual disorders. Neurology 36, 1607-1610.
      27. SUKUMARAN SC, SARMA PS, THOMAS SV (2010) Polytherapy increases the risk of infertility in women
            with epilepsy. Neurology 75, 1351-1355.
      28. ISOJARVI JI, LAATIKAINEN TJ, PAKARINEN AJ, JUNTUNEN KT, MYLLYLA VV (1993) Polycystic
            ovaries and hyperandrogenism in women taking valproate for epilepsy. N Engl J Med 329, 1383-1388.
   437   438   439   440   441   442   443   444   445   446   447